Search Results - "Florescu, Alexandru"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    FGF23 Beyond the Kidney: A New Bone Mass Regulator in the General Population by Bilha, Stefana Catalina, Bilha, Andrei, Ungureanu, Maria-Christina, Matei, Anca, Florescu, Alexandru, Preda, Cristina, Covic, Adrian, Branisteanu, Dumitru

    Published in Hormone and metabolic research (01-05-2020)
    “…Clinical studies investigating the relationship between fibroblast growth factor 23 (FGF23) and bone mass are controversial, especially in the healthy renal…”
    Get more information
    Journal Article
  2. 2

    Leptin and adiponectin dynamics at patients with rectal neoplasm - Gender differences by Florescu, Alexandru, Branisteanu, Dumitru, Bilha, Stefana, Scripcariu, Dragos, Florescu, Ioana, Scripcariu, Viorel, Dimofte, Gabriel, Grigoras, Ioana

    Published in PloS one (19-08-2019)
    “…Numerous studies associate adipokines with colorectal malignancy, but few data deal with patients suffering exclusively of rectal carcinoma (RC). We evaluated…”
    Get full text
    Journal Article
  3. 3

    Insights into Hyperparathyroidism-Jaw Tumour Syndrome: From Endocrine Acumen to the Spectrum of CDC73 Gene and Parafibromin-Deficient Tumours by Gheorghe, Ana-Maria, Sima, Oana-Claudia, Florescu, Alexandru Florin, Ciuche, Adrian, Nistor, Claudiu, Sandru, Florica, Carsote, Mara

    “…A total of 1 out of 10 patients with primary hyperparathyroidism (PHP) presents an underlying genetic form, such as multiple endocrine neoplasia types 1, 2A,…”
    Get full text
    Journal Article
  4. 4

    Zoledronic acid: challenges and pitfalls amid rehabilitation in primary osteoporosis and beyond by Florescu, Alexandru Florin, Sima, Oana-Claudia, Costăchescu, Mihai, Stanciu, Mihaela, Popa, Ligia Florina, Nistor, Claudiu, Iliescu, Mădălina Gabriela, Ciobica, Mihai-Lucian, Carsote, Mara

    “…Zoledronate (or zoledronic acid) represents a standard (guideline-based) approach in the area of anti-resorptive medication (namely, an annual 15-minute…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Insights into Hyperparathyroidism–Jaw Tumour Syndrome: From Endocrine Acumen to the Spectrum of ICDC73/I Gene and Parafibromin-Deficient Tumours by Gheorghe, Ana-Maria, Sima, Oana-Claudia, Florescu, Alexandru Florin, Ciuche, Adrian, Nistor, Claudiu, Sandru, Florica, Carsote, Mara

    “…A total of 1 out of 10 patients with primary hyperparathyroidism (PHP) presents an underlying genetic form, such as multiple endocrine neoplasia types 1, 2A,…”
    Get full text
    Journal Article
  7. 7

    Incidence of transient and chronic hypoparathyroidism after total thyroidectomy - the experience of a tertiary center by Velicescu, Cristian, Bilha, Stefana Catalina, Teleman, Alexandra, Vitelariu, Andrada, Teodoriu, Laura, Florescu, Alexandru, Novac, Roxana

    Published in Archive of clinical cases (01-09-2024)
    “…The most common cause of hypoparathyroidism (hypoPT) in adults is iatrogenic due to total thyroidectomy, while the ideal moment for considering it chronic is…”
    Get full text
    Journal Article
  8. 8

    Endocrine Perspective of Cutaneous Lichen Amyloidosis: RET-C634 Pathogenic Variant in Multiple Endocrine Neoplasia Type 2 by Florescu, Alexandru-Florin, Sima, Oana-Claudia, Nistor, Claudiu, Ciobica, Mihai-Lucian, Costachescu, Mihai, Stanciu, Mihaela, Tanasescu, Denisa, Popa, Florina Ligia, Carsote, Mara

    Published in Clinics and practice (29-10-2024)
    “…Background: Medullary thyroid carcinoma (MTC), the third most frequent histological type of thyroid malignancy, may be found isolated or as part of multiple…”
    Get full text
    Journal Article
  9. 9

    FGF23 and primary hyperparathyroidism: is there a link? by Bilha, Stefana Catalina, Gatu, Alina Andreea, Velicescu, Cristian, Bilha, Andrei, Florescu, Alexandru, Branisteanu, Dumitru

    Published in Endokrynologia polska (2020)
    “…INTRODUCTION: Data regarding the role of fibroblast growth factor 23 (FGF23) in primary hyperparathyroidism (PHPT) are scarce and discordant. Our study aimed…”
    Get full text
    Journal Article
  10. 10

    Morphology and one immunohistochemical marker are enough for diagnosis of primary thyroid angiosarcoma by Negura, Ion, Badescu, Minerva Codruta, Rezus, Ciprian, Danila, Radu, Florescu, Alexandru Florin, Blaj, Mihaela, Morosan, Eugenia, Gabriela, Delia, Apostol, Ciobanu

    Published in Archive of clinical cases (01-03-2021)
    “…Primary thyroid angiosarcoma is a very rare and extremely aggressive mesenchymal malignant neoplasm showing morphological and immunophenotypic evidence of…”
    Get full text
    Journal Article
  11. 11
  12. 12